In-depth review of Arcanum Pulse, a non-custodial crypto trading bot on Telegram for Bybit. Features risk mitigation & a success-based fee model.

The Russian billionaire who founded messaging app Telegram is fighting infertility, but he isn’t using his wallet — he is using his own sperm. Pavel Durov, 41, has offered to cover the full cost of in ...

Forbes contributors publish independent expert analyses and insights. Davey Winder is a veteran cybersecurity writer, hacker and analyst. Updated November 25 with a new warning from America’s Cyber ...

“What if I could come home to you right now?” “Please do, my sweet king.” Those were the last messages exchanged by 14-year-old Sewell Setzer and the chatbot he developed a romantic relationship with ...

Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...

Google has relaunched its Androidify app, now using AI to create custom Android Bot avatars from your photos or text prompts. The new app leverages Google’s Gemini 2.5 Flash and Imagen AI models to ...

Russian regulators have moved to restrict usage of the popular messaging apps WhatsApp and Telegram, the latest in a major step to push Russians onto a newly launched government-managed "super app." ...

Abdullah is a certified Google IT Support Professional. @SpamBot is an official Telegram bot that helps users verify if their accounts are restricted due to spamming and provides steps to appeal.

This volume-leading Telegram-based crypto trading bot brings speed, advanced tools and a user-first approach to the DeFi trading space. Drawn by the promise of transparency and individualized control, ...

I'm an independent creator passionate about building useful tools, simulations, and theories that make complex ideas more accessible. I explore the intersection of technology, education, and human ...

Replimune Group, Inc. (NASDAQ:REPL) stock plunged on Tuesday after a U.S. Food and Drug Administration (FDA) update. The clinical stage biotechnology company received an FDA Complete Response Letter ...